As of 2025-12-31, the Relative Valuation of Heron Therapeutics Inc (HRTX) is (1.46) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.31 USD, the upside of Heron Therapeutics Inc based on Relative Valuation is -211.8%.
The range of the Relative Valuation is (1.33) - (1.35) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.9x - 25.1x | 21.5x |
| Forward P/E multiples | 17.9x - 18.2x | 18.0x |
| Fair Price | (1.33) - (1.35) | (1.46) |
| Upside | -201.2% - -202.9% | -211.8% |
| Date | P/E |
| 2025-12-29 | -17.69 |
| 2025-12-26 | -17.29 |
| 2025-12-24 | -17.29 |
| 2025-12-23 | -17.29 |
| 2025-12-22 | -18.10 |
| 2025-12-19 | -17.56 |
| 2025-12-18 | -17.42 |
| 2025-12-17 | -17.15 |
| 2025-12-16 | -18.64 |
| 2025-12-15 | -18.91 |
| 2025-12-12 | -18.50 |
| 2025-12-11 | -18.50 |
| 2025-12-10 | -18.50 |
| 2025-12-09 | -17.96 |
| 2025-12-08 | -18.23 |
| 2025-12-05 | -17.69 |
| 2025-12-04 | -17.69 |
| 2025-12-03 | -17.15 |
| 2025-12-02 | -15.80 |
| 2025-12-01 | -15.53 |
| 2025-11-28 | -15.66 |
| 2025-11-26 | -15.12 |
| 2025-11-25 | -14.72 |
| 2025-11-24 | -15.26 |
| 2025-11-21 | -14.31 |
| 2025-11-20 | -14.25 |
| 2025-11-19 | -14.72 |
| 2025-11-18 | -15.12 |
| 2025-11-17 | -14.72 |
| 2025-11-14 | -14.85 |
| 2025-11-13 | -14.99 |
| 2025-11-12 | -14.99 |
| 2025-11-11 | -15.66 |
| 2025-11-10 | -14.99 |
| 2025-11-07 | -14.85 |
| 2025-11-06 | -14.85 |
| 2025-11-05 | -14.99 |
| 2025-11-04 | -15.39 |
| 2025-11-03 | -15.93 |
| 2025-10-31 | -15.66 |
| 2025-10-30 | -15.39 |
| 2025-10-29 | -15.80 |
| 2025-10-28 | -16.07 |
| 2025-10-27 | -15.93 |
| 2025-10-24 | -16.21 |
| 2025-10-23 | -16.07 |
| 2025-10-22 | -16.07 |
| 2025-10-21 | -17.56 |
| 2025-10-20 | -18.23 |
| 2025-10-17 | -17.42 |